Why the study?
Does maternal administration of flecainide terminate and suppress fetal tachycardia?
Does maternal administration of flecainide terminate and suppress fetal tachycardia?
Maternal administration of flecainide successfully terminated and suppressed fetal tachycardia complicated by hydrops that was refractory to digoxin.
Maternal IV flecainide may rapidly terminate refractory fetal tachycardia with hydrops; leaves open confirmation of efficacy and safety in prospective studies.
Maternal administration offlecainide to terminate and suppress fetal tachycardiaFetal echocardiography has allowed fetal arrhythmias to be identified and accurately diagnosed.Because a fetal tachycardia is often detected before an elective delivery is safe considerable interest has focused on treatment by giving drugs to the mother.Digoxin is accepted as the drug of first choice, but no consensus exists on second line drugs.' 2 We present the first report of giving flecainide to a mother to terminate and suppress a fetal tachycardia.Case report
No takes yet. Share an insight, caveat, or question.
Stephen K. Hunter (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: